Bank of Montreal
BMO
Royal Bank of Canada
RY
The Toronto-Dominion Bank
TD
4
Canadian Imperial Bank of Commerce
CM
5
Bank of Nova Scotia
BNS
(Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 31.18%-60.61K | 83.84%-103.4K | -269.43%-49.11K | 3,405.59%54.44K | 97.81%-13.05K | -22.89%-88.07K | 75.15%-639.94K | 105.47%28.98K | 99.79%-1.65K | -10.45%-595.62K |
Net income from continuing operations | 28.63%-186.23K | 76.88%-710.77K | 80.22%-239.06K | 98.22%-9.77K | 69.75%-200.98K | 60.02%-260.95K | 24.42%-3.07M | -6.68%-1.21M | 57.36%-548.24K | 36.10%-664.3K |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | 22.14%-20.44K | -0.55%-22.59K | ---- | ---- |
Depreciation and amortization | 3.78%27.72K | -91.99%49.28K | -95.11%7.47K | -95.07%7.54K | -95.06%7.57K | -82.92%26.71K | 62.57%615.16K | -6.06%152.7K | -6.02%152.96K | 294.02%153.12K |
Asset impairment expenditure | ---- | -91.39%74.98K | ---- | ---- | ---- | ---- | --870.41K | ---- | ---- | ---- |
Remuneration paid in stock | 231.23%4.21K | -90.66%23K | 4,221.57%4.2K | -83.54%4.21K | -72.76%17.8K | -102.06%-3.21K | -59.94%246.2K | -100.06%-102 | -90.43%25.55K | -62.58%65.34K |
Other non cashItems | 11.95%32.48K | 236.34%122.65K | 10.39%31.83K | 6.63%31.2K | 80.02%30.61K | 117.58%29.02K | -170.44%-89.96K | -18.13%28.83K | -10.20%29.26K | -44.79%17K |
Change In working capital | -49.14%61.22K | -58.47%337.46K | -65.68%71.47K | -93.72%21.27K | 179.13%131.97K | -72.15%120.37K | 104.61%812.5K | -18.53%208.24K | 420.84%338.83K | -166.09%-166.78K |
-Change in receivables | -138.84%-34.46K | 156.17%56.26K | 76.68%-28.19K | 2.16%87.87K | 15.84%-84.52K | 152.24%88.72K | -154.52%-100.16K | -194.98%-120.92K | 747.34%86.02K | -82,219.67%-100.43K |
-Change in inventory | 202.72%5.36K | -87.32%2.56K | 374.26%40.45K | -270.21%-7.56K | -122.30%-25.11K | 95.04%-5.22K | 392.99%20.23K | -76.45%8.53K | 111.87%4.44K | 8,000.07%112.59K |
-Change in prepaid assets | 772.05%19.12K | -499.25%-297.52K | 2,150.97%22.09K | -4,159.31%-139.76K | -832.30%-182.04K | -95.36%2.19K | 292.28%74.52K | -101.08%-1.08K | -94.98%3.44K | -74.08%24.86K |
-Change in payables and accrued expense | 4,475.08%80.76K | -87.97%110.92K | -101.28%-4.13K | -56.01%123.22K | -118.17%-6.32K | -100.65%-1.85K | 348.79%921.79K | 1,148.92%324.08K | 973.37%280.12K | -53.01%34.78K |
-Change in other working capital | -126.20%-9.57K | 547.84%465.23K | 1,836.24%41.25K | -20.75%-42.5K | 280.21%429.96K | -78.80%36.52K | -293.63%-103.88K | 92.94%-2.38K | -144.41%-35.2K | -393.86%-238.58K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 31.18%-60.61K | 83.84%-103.4K | -269.43%-49.11K | 3,405.59%54.44K | 97.81%-13.05K | -22.89%-88.07K | 75.15%-639.94K | 105.47%28.98K | 99.79%-1.65K | -10.45%-595.62K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | -3.80%-1.12K | 0 | -2.14K | 0 | 1.02K | -100.61%-1.08K | -99.98%32 | 0 | -1.11K |
Net PPE purchase and sale | ---- | -98.05%-2.14K | --0 | ---2.14K | --0 | ---- | 66.49%-1.08K | --32 | --0 | ---1.11K |
Net business purchase and sale | --0 | --1.02K | --0 | --0 | --0 | --1.02K | --0 | --0 | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | -3.80%-1.12K | --0 | ---2.14K | --0 | --1.02K | -100.61%-1.08K | -99.98%32 | --0 | ---1.11K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 143.31%68.32K | -84.49%92.76K | -123.32%-17.48K | 56.20%-17.49K | -76.22%99.65K | -80.50%28.08K | -71.17%598.14K | -72.90%74.97K | -121.30%-39.92K | -55.80%419.11K |
Net issuance payments of debt | -222.46%-17.48K | 74.76%-53.82K | -199.48%-17.49K | 60.64%-17.49K | 95.94%-13.42K | -103.77%-5.42K | -208.36%-213.23K | -92.57%17.58K | -233.08%-44.42K | -2,388.60%-330.36K |
Net common stock issuance | 156.12%85.8K | -81.51%151K | --0 | --0 | -84.43%117.5K | --33.5K | -55.70%816.68K | --57.4K | -97.20%4.5K | -23.49%754.79K |
Cash dividends paid | ---- | --0 | --0 | --0 | --0 | ---- | --0 | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | ---- | ---4.42K | --2 | --0 | ---4.43K | ---- | --0 | --0 | --0 | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | 91.88%-5.32K | --0 | ---- | 88.21%-5.32K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 143.31%68.32K | -84.49%92.76K | -123.32%-17.48K | 56.20%-17.49K | -76.22%99.65K | -80.50%28.08K | -71.17%598.14K | -72.90%74.97K | -121.30%-39.92K | -55.80%419.11K |
Net cash flow | ||||||||||
Beginning cash position | -13.99%72.24K | -33.80%84K | 1,098.54%199.62K | 663.68%164.8K | -60.75%78.19K | -33.80%84K | -71.81%126.88K | -110.02%-19.99K | -97.24%21.58K | -46.65%199.2K |
Current changes in cash | 113.07%7.71K | 72.59%-11.76K | -164.04%-66.59K | 183.77%34.82K | 148.76%86.61K | -181.55%-58.97K | 86.73%-42.88K | 243.30%103.99K | 92.87%-41.57K | -143.43%-177.62K |
End cash Position | 219.49%79.95K | -13.99%72.24K | -13.99%72.24K | 1,098.54%199.62K | 663.68%164.8K | -87.44%25.03K | -33.80%84K | -33.80%84K | -110.02%-19.99K | -97.24%21.58K |
Free cash from | 31.18%-60.61K | 83.54%-105.53K | -269.25%-49.11K | 3,275.96%52.31K | 97.81%-13.05K | -22.89%-88.07K | 75.14%-641.02K | 105.47%29.02K | 99.79%-1.65K | -10.65%-596.73K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.